Calidi Biotherapeutics, Inc.CLDINYSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank35
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P35
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -11.06% |
| Q2 2025 | 9.95% |
| Q1 2025 | 31.37% |
| Q4 2024 | 58.72% |
| Q3 2024 | 53.57% |
| Q2 2024 | 31.20% |
| Q1 2024 | 12.16% |
| Q4 2023 | -63.82% |
| Q3 2023 | 67.26% |
| Q2 2023 | -92.00% |
| Q1 2023 | 14.12% |
| Q4 2022 | -1478.95% |
| Q3 2022 | -86.90% |
| Q2 2022 | 184.31% |
| Q1 2022 | -65.77% |
| Q4 2021 | 613.79% |
| Q3 2021 | -8185.71% |
| Q2 2021 | 0.00% |